EATONTOWN, N.J., Oct. 12 /PRNewswire-FirstCall/ -- Osteotech, Inc.
(Nasdaq: OSTE) today issued the following statement in response to questions
the Company has received regarding Biomedical Tissue Services Ltd., as a
result of recent stories in the media.
We want to assure our customers, partners, shareholders, and employees,
that Osteotech and the entities through which Osteotech receives donor tissue,
do not conduct and have never conducted, business with Biomedical Tissue
Services Ltd.
Osteotech is committed to upholding the highest ethical standards and
strictest screening processes to ensure the safety of all tissue processed and
released by Osteotech.
Osteotech, Inc., headquartered in Eatontown, New Jersey, is a leading
provider of human bone and bone connective tissue for transplantation and an
innovator in the development and marketing of biomaterial and implant products
for musculoskeletal surgery. For further information regarding Osteotech or
this press release, please go to Osteotech's website homepage at
http://www.osteotech.com and to Osteotech's Financial Information Request Form
website page at http://www.osteotech.com/finrequest.htm.
SOURCE Osteotech, Inc.
 back to top
Related links:
http://www.osteotech.com
http://www.osteotech.com/finrequest.htm
Company News On-Call:
http://www.prnewswire.com/comp/668050.html
CONTACT:
Michael J. Jeffries of Osteotech, Inc.,
+1-732-542-2800
|
